Salesforce, Inc.
—- Market cap
- —
- Debt
- —
- Cash
- −$7.33B
Complete market value, debt and cash evidence is required for enterprise value.
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: CRM stock price vs ACN: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at ACN's multiple
Needs ACN P/E.
Implied fair value · at CRM's multiple
Needs CRM P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Eight period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
Salesforce, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Accenture plc · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
MICROSOFT CORP
CRM vs MSFT
ORACLE CORP
CRM vs ORCL
ADOBE INC.
CRM vs ADBE
Workday, Inc.
CRM vs WDAY
INTUIT INC.
CRM vs INTU
Paycom Software, Inc.
CRM vs PAYC
INTERNATIONAL BUSINESS MACHINES CORP
CRM vs IBM
COGNIZANT TECHNOLOGY SOLUTIONS CORP
CRM vs CTSH
DXC Technology Co
CRM vs DXC
Infosys Ltd
CRM vs INFY
MARSH & MCLENNAN COMPANIES, INC.
CRM vs MMC
ROBERT HALF INC.
CRM vs RHI
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CRM can sustain a premium multiple despite trading well above ACN and DCF valuation ranges, then hold or add selectively; otherwise, reduce exposure because CRM's current price embeds valuation upside that is not matched by a proportionate fundamental advantage over ACN.
CRM's current price of $189.57 sits far above ACN implied range of $76.63-$123.87 and above the DCF range of $81.75-$110.61, implying meaningful overvaluation on both relative and intrinsic bases. The only supportive anchor is the historical band of $170.61-$208.53, but even there CRM is near the upper half of the range rather than discounted.
Supporting Metrics